Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Feb. 2, 2015, 49 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $144.84 to $41,551,800.00.

Highlighted Stocks Traded by Insiders:

Renasant (RNST) - FREE Research Report

Dickerson Marshall, who is Director at Renasant, sold 1,183 shares at $26.51 on Feb. 2, 2015. Following this transaction, the Director owned 5,982 shares meaning that the stake was reduced by 16.51% with the 1,183-share transaction.

The shares most recently traded at $27.24, up $0.73, or 2.68% since the insider transaction. Historical insider transactions for Renasant go as follows:

  • 4-Week # shares bought: 4,300
  • 4-Week # shares sold: 2,500
  • 12-Week # shares bought: 4,300
  • 12-Week # shares sold: 2,500
  • 24-Week # shares bought: 4,300
  • 24-Week # shares sold: 2,500

The average volume for Renasant has been 125,700 shares per day over the past 30 days. Renasant has a market cap of $825.0 million and is part of the financial sector and banking industry. Shares are down 6.33% year-to-date as of the close of trading on Monday.

Renasant Corporation, through its subsidiaries, provides financial, fiduciary, and insurance services to retail and commercial customers. It operates through three segments: Community Banks, Insurance, and Wealth Management. The stock currently has a dividend yield of 2.6%. The company has a P/E ratio of 14.9. Currently, there are 6 analysts who rate Renasant a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RNST - FREE

TheStreet Quant Ratings

rates Renasant as a

buy

. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, expanding profit margins and notable return on equity. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full

Renasant Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Kemet (KEM) - FREE Research Report

Borruso Joseph Vincent, who is Director at Kemet, bought 1,000 shares at $3.78 on Feb. 2, 2015. Following this transaction, the Director owned 46,867 shares meaning that the stake was boosted by 2.18% with the 1,000-share transaction.

The shares most recently traded at $3.91, up $0.13, or 3.33% since the insider transaction. Historical insider transactions for Kemet go as follows:

  • 24-Week # shares bought: 1,000

The average volume for Kemet has been 218,800 shares per day over the past 30 days. Kemet has a market cap of $172.5 million and is part of the technology sector and electronics industry. Shares are down 9.52% year-to-date as of the close of trading on Monday.

KEMET Corporation, together with its subsidiaries, manufactures and sells various capacitors under the KEMET brand worldwide. The company operates through two segments, Film and Electrolytic Business Group and Solid Capacitors Business Group. Currently, there are no analysts who rate Kemet a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on KEM - FREE

TheStreet Quant Ratings

rates Kemet as a

sell

. The company's weaknesses can be seen in multiple areas, such as its weak operating cash flow, generally disappointing historical performance in the stock itself, generally high debt management risk and poor profit margins. Get the full

Kemet Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

RLI (RLI) - FREE Research Report

Scanlan James J., who is Director at RLI, bought 5,500 shares at $46.94 on Feb. 2, 2015. Following this transaction, the Director owned 5,500 shares meaning that the stake was boosted by 100% with the 5,500-share transaction.

The shares most recently traded at $49.43, up $2.49, or 5.04% since the insider transaction. Historical insider transactions for RLI go as follows:

  • 4-Week # shares bought: 600
  • 4-Week # shares sold: 1,000
  • 12-Week # shares bought: 600
  • 12-Week # shares sold: 8,000
  • 24-Week # shares bought: 600
  • 24-Week # shares sold: 8,000

The average volume for RLI has been 135,400 shares per day over the past 30 days. RLI has a market cap of $2.0 billion and is part of the financial sector and insurance industry. Shares are down 1.17% year-to-date as of the close of trading on Monday.

RLI Corp., through its subsidiaries, underwrites property and casualty insurance primarily in the United States. The stock currently has a dividend yield of 1.53%. The company has a P/E ratio of 15.2. Currently, there are no analysts who rate RLI a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on RLI - FREE

TheStreet Quant Ratings

rates RLI as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and growth in earnings per share. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full

RLI Ratings Report

from

TheStreet Quant Ratings

now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null